Adenocarcinomas with CD74-ROS1 fusion, which is the most frequent fusion gene, usually shows globular cytoplasmic ROS1 immunoreactivity, whereas adenocarcinomas with EZR-ROS1 fusion usually show membranous immunostaining [48]. This evidence concerns the gene ROS1 and adenocarcinoma.